The report provides a detailed analysis essential for establishing a Flunisolide production plant. It encompasses all critical aspects necessary for Flunisolide production, including the cost of Flunisolide production, Flunisolide plant cost, Flunisolide production costs, and the overall Flunisolide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Flunisolide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Flunisolide is a synthetic corticosteroid that is mainly used for its anti-inflammatory effects. It is widely utilised as a medication in the treatment of respiratory conditions, especially asthma and allergic rhinitis. It is generally used as a nasal spray or inhalation medicine to reduce inflammation in the airways, which makes it easier for patients to breathe. It prevents asthma symptoms like wheezing and shortness of breath. It also finds its application as nasal sprays for relieving symptoms of nasal allergies, such as sneezing, runny nose, nasal congestion, and breathing difficulty by controlling swelling and irritation. It is also sometimes prescribed for managing chronic conditions like seasonal or year-round allergic reactions. Additionally, it is also used in clinical practice and medical research related to anti-inflammatory therapies and respiratory disease management.
The primary factor that drives the market for Flunisolide is its application in managing allergic rhinitis, asthma, and other inflammatory nasal disorders, which significantly boosts its demand in the medical sector. Its usage as a corticosteroid to manage respiratory and nasal inflammatory conditions, including asthma and allergic rhinitis, strongly supports its demand in the healthcare sector. Its application as a part of long-term maintenance therapy in the treatment of respiratory conditions like asthma further promotes its demand in the medical and pharmaceutical industries.
The rising prevalence of respiratory disorders, increasing exposure to allergens, and growing awareness of long-term inflammation control also drive its market growth. In addition, industrial Flunisolide procurement is influenced by factors such as the availability and pricing of raw materials, compliance with pharmaceutical regulations, and adherence to quality and safety standards. Advancements in inhalation and nasal drug delivery systems, dependable supplier networks, regulatory approvals, and efficient distribution channels also play a major role in shaping its global procurement processes.
Raw Material for Flunisolide Production
According to the Flunisolide production plant project report, the major raw materials for Flunisolide production include Fermentation mash containing 6α-fluoroprednisolone, Streptomyces roseochromogenus Culture, and Ethyl Acetate.
Production Process of Flunisolide
The extensive Flunisolide production cost report consists of the following industrial production process:
- Production via ChemicaL Synthesis: The production process of Flunisolide begins with the formation of 6α-fluoro-16α-hydroxyprednisolone from a fermented mash produced by Streptomyces roseochromogenus. Then, the filtrate and mycelium are extracted with ethyl acetate, and the combined organic layers are purified through washing, concentration, and partition chromatography to isolate the fluorinated steroid. Further, this purified intermediate is dissolved in acetone and treated with a small amount of perchloric acid to promote the formation of the 16α,17α-isopropylidene acetal. This creates the protected ketal structure characteristic of flunisolide. Once the reaction is complete, the mixture is neutralised with sodium bicarbonate, concentrated, and allowed to crystallise. Finally, the resulting solid is filtered, washed, and recrystallised to give flunisolide in purified crystalline form as the desired product.
Flunisolide appears as a white to off-white crystalline powder with no distinct odour. It is a synthetic corticosteroid used in treating allergic rhinitis and asthma. It is generally handled and formulated into pharmaceutical preparations rather than as a neat liquid. The molecular formula of the compound is C24H31FO6, and its molar mass is 434.50 g/mol. It has a density of about 1.33 g/cm3 in the solid state, and exhibits a decomposition melting point of approximately 237–240 degree Celsius. Its boiling point is around 581.8 degree Celsius.
The flash point of the compound is near 305.7 degree Celsius under standard conditions. It has a complex fluorinated pregnadiene structure and is soluble in organic solvents such as dimethylformamide, dimethyl sulfoxide, and ethanol, but only sparingly in water. Flunisolide is an active pharmaceutical ingredient, and it must be handled with appropriate protective measures to avoid exposure. Improper use or accidental ingestion of the compound can lead to adverse health effects consistent with corticosteroid toxicity.